Research Article| Volume 283, ISSUE 1-2, P214-218, August 15, 2009

New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia

Published:March 09, 2009DOI:



      Few studies confirm that pharmacological treatments support post-stroke recovery. The purpose of this study was to determine whether the combination of levodopa with language therapy improves aphasia rehabilitation.


      We did a prospective, randomized, placebo-controlled, double-blind study in which twenty patients received levodopa before each language therapy session, and an additional 19 received a placebo. Language training was provided during a 3-week period. The efficacy variables were changes from baseline in Boston Diagnostic Aphasia Examination (BDAE) scores.


      Patients receiving levodopa experienced greater language improvement in verbal fluency and repetition, compared to patients receiving placebo. Improvement was particularly distinct in patients with anterior lesions.


      Supplementing language therapy with levodopa may improve recovery from aphasia in patients with frontal lesions.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cicerone K.
        • Dahlberg C.
        • Malec J.M.
        • et al.
        Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002.
        Arch Phys Med Rehabil. 2005; 68: 1681-1692
        • Cappa S.F.
        • Benke T.
        • Clarke B.
        • et al.
        EFNS guidelines on cognitive rehabilitation: report of an EFNS task force.
        Eur J Neurol. 2005; 12: 665-680
        • Berthier M.L.
        • Hinojosa J.
        • Del Carmen M.
        • et al.
        Open-label study of donepezil in chronic post stroke aphasia.
        Neurology. 2003; 60: 1218-1219
        • Gold M.
        • VanDam D.
        • Silliman E.R.
        An open-label trial of bromocriptine in nonfluent aphasia: a qualitative analysis of word storage and retrieval.
        Brain Lang. 2000; 74: 141-146
        • Walker-Batson D.
        • Curtis S.
        • Natarajan R.
        • et al.
        A double-blind, placebo controlled study of the use of amphetamine in the treatment of aphasia.
        Stroke. 2001; 32: 2093-2098
        • Kessler J.
        • Thiel A.
        • Karbe H.
        • et al.
        Piracetam improves activated blood flow and facilitates rehabilitation of post-stroke aphasic patients.
        Stroke. 2000; 31: 2112-2116
        • Scheidtmann K.
        • Fries W.
        • Muller F.
        • et al.
        Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, double-blind study.
        Lancet. 2001; 358: 787-789
        • Walker-Batson D.
        • Smith P.
        • Curtis S.
        • et al.
        Amphetamine paired with physical therapy accelerates motor recovery after stroke — further evidence.
        Stroke. 1995; 26: 2254-2259
        • Bragoni M.
        • Altieri M.
        • Di Piero V.
        • et al.
        Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke.
        Neuroscience. 2000; 21: 19-22
        • Tanaka Y.
        • Albert M.L.
        • Nonaka C.
        • et al.
        Cholinergic therapy for fluent aphasia.
        in: Paper presented at the meeting of the American Neurological Association. Chicago. September 2001
        • Nutt J.G.
        • Fellman J.H.
        Pharmacokinetics of levodopa.
        Clin Neuropharmacol. 1984; 7: 35-49
        • Knecht S.
        • Breitenstein C.
        • Bushuven S.
        • et al.
        Levodopa: faster and better word learning in normal humans.
        Ann Neurol. 2004; 56: 20-26
        • Albert M.L.
        • Bachman D.L.
        • Morgan A.
        • et al.
        Pharmacotherapy for aphasia.
        Neurology. 1998; 38: 877-879
        • Gupta S.R.
        • Mlcoch A.G.
        Bromocriptine treatment of nonfluent aphasia.
        Arch Phys Med Rehabil. 1992; 73: 373-376
        • Raymer A.M.
        • Bandy D.
        • Adair J.C.
        Effects of bromocriptine in a patient with crossed nonfluent aphasia: a case report.
        Arch Phys Med Rehabil. 2001; 82: 139-144
        • Sabe L.
        • Leiguarda R.
        • Starkstein S.E.
        An open-label trial of bromocriptine in nonfluent aphasia.
        Neurology. 1992; 42: 1637-1638
        • Sabe L.
        • Salvarezza F.
        • Cuerva A.G.
        • et al.
        A randomized, double-blind, placebo controlled study of bromocriptine in nonfluent aphasia.
        Neurology. 1995; 45: 2272-2274
        • Gupta S.R.
        • Mlcoch A.G.
        • Scolaro C.
        • et al.
        Bromocriptine treatment of nonfluent aphasia.
        Neurology. 1995; 45: 2170-2173
        • Goodglass H.
        • Kaplan E.
        The assessment of aphasia and related disorders.
        Lea & Febiger, Philadelphia1972
        • Johansson B.B.
        Brain plasticity and stroke rehabilitation.
        Stroke. 2000; 31: 223-230
        • Stroemer R.P.
        • Kent T.A.
        • Hulsebosch C.E.
        Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats.
        Stroke. 1998; 29: 2381-2395
        • Queen S.A.
        • Chen M.J.
        • Feeney D.M.
        d-amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats.
        Brain Res. 1997; 777: 42-50
        • Sutton R.L.
        • Hovda D.A.
        • Chen M.J.
        • et al.
        Alleviation of brain injury-induced cerebral metabolic depression by amphetamine: a cytochroma oxidase histochemistry study.
        Neural Plast. 2000; 7: 109-125
        • Robbins T.W.
        Chemical neuromodulation of frontal-executive functions inhumans and other animals.
        Exp Brain Res. 2000; 133: 130-138
        • McDowell S.
        • Whyte J.
        • D'Esposito M.
        Differential effect of dopaminergic agonist on prefrontal function in traumatic brain ipatients.
        Brain. 1998; 121: 1155-1164
        • Haig A.J.
        • Ruess J.M.
        Recovery from vegetative state of six months duration associated with Sinemet (levodopa/carbidopa).
        Arch Phys Med Rehabil. 1990; 17: 1081-1083
        • Arnsten A.F.T.
        Catecholamine regulation of the prefrontal cortex.
        J Psychopharmacol. 1997; 11: 151-162